|
|
Article: Antares Pharma's Licensee Reaches Important Milestone.
- Article from:
- PR Newswire
- Article date:
- January 19, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Antares Pharma's North American Licensee, BioSante Pharmaceuticals, Inc., Completes Enrollment in Pivotal Phase III Clinical Trial for Estradiol Gel
Antares Pharma, Inc. announced today that its North American licensee, BioSante Pharmaceuticals, Inc. , has completed enrollment of more than 450 women in a pivotal Phase III clinical trial for its transdermal bioidentical estradiol gel, Bio-E-Gel(TM). The clinical trial will evaluate the safety and efficacy of Bio-E-Gel(TM) for the treatment of moderate-to-severe hot flashes in menopausal women. Hot flashes occur in up to 85% of menopausal women. BioSante further announced that they expect to complete the trial ...